Literature DB >> 8020261

Mechanism of periodic breathing in patients with cardiovascular disease.

T Yajima1, A Koike, K Sugimoto, Y Miyahara, F Marumo, M Hiroe.   

Abstract

Although periodic breathing consisting of alternating hyperpnea and hypopnea has been recognized in heart failure patients, its mechanism has not been clarified. We hypothesized that heart failure patients who have oscillations in ventilation will also be found to have oscillations in pulmonary blood flow, as reflected in left ventricular ejection fraction. To test this hypothesis, we analyzed continuously gas exchange and left ventricular ejection fraction during exercise in cardiac patients who exhibited periodic breathing. Out of 48 consecutive patients with reduced left ventricular function who performed a symptom-limited incremental exercise test using an upright cycle ergometer, we selected 5 patients who exhibited clear ventilatory oscillations during exercise. These patients repeated the same exercise test on another day for measuring gas exchange and left ventricular ejection fraction continuously. Oscillatory changes were noted both in left ventricular ejection fraction and in ventilation in these patients. These observations offer support for the hypothesis that fluctuations in pulmonary blood flow are primarily responsible for the periodic breathing seen in heart failure patients.

Entities:  

Mesh:

Year:  1994        PMID: 8020261     DOI: 10.1378/chest.106.1.142

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  11 in total

1.  Increased interbreath variability of gas exchange during exercise in children with cardiomyopathy.

Authors:  Tony Reybrouck; Steven Vangesselen; Luc Mertens; Marc Gewillig
Journal:  Heart       Date:  2007-03       Impact factor: 5.994

2.  Effects of acute changes in pulmonary wedge pressure on periodic breathing at rest in heart failure patients.

Authors:  Thomas P Olson; Robert P Frantz; Eric M Snyder; Kathy A O'Malley; Kenneth C Beck; Bruce D Johnson
Journal:  Am Heart J       Date:  2007-01       Impact factor: 4.749

Review 3.  Abnormalities in cardiopulmonary exercise testing ventilatory parameters in heart failure: pathophysiology and clinical usefulness.

Authors:  Marco Guazzi
Journal:  Curr Heart Fail Rep       Date:  2014-03

Review 4.  Exercise oscillatory ventilation: Mechanisms and prognostic significance.

Authors:  Bishnu P Dhakal; Gregory D Lewis
Journal:  World J Cardiol       Date:  2016-03-26

5.  Breathing pattern characterization in chronic heart failure patients using the respiratory flow signal.

Authors:  A Garde; L Sörnmo; R Jané; B F Giraldo
Journal:  Ann Biomed Eng       Date:  2010-07-08       Impact factor: 3.934

6.  Correlations of physiological activities in nocturnal Cheyne-Stokes respiration.

Authors:  Alexander Umantsev; Alexander Golbin
Journal:  Nat Sci Sleep       Date:  2011-01-11

7.  Different ventilatory responses to progressive maximal exercise test performed with either the arms or legs.

Authors:  Renata R T Castro; Sabrina Pedrosa; Antonio C L Nóbrega
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

8.  Feasibility of high-resolution quantitative perfusion analysis in patients with heart failure.

Authors:  Eva Sammut; Niloufar Zarinabad; Roman Wesolowski; Geraint Morton; Zhong Chen; Manav Sohal; Gerry Carr-White; Reza Razavi; Amedeo Chiribiri
Journal:  J Cardiovasc Magn Reson       Date:  2015-02-12       Impact factor: 5.364

Review 9.  Contribution of Peripheral Chemoreceptors to Exercise Intolerance in Heart Failure.

Authors:  Katarzyna Kulej-Lyko; Piotr Niewinski; Stanislaw Tubek; Piotr Ponikowski
Journal:  Front Physiol       Date:  2022-04-14       Impact factor: 4.755

10.  Minute-Ventilation Variability during Cardiopulmonary Exercise Test is Higher in Sedentary Men Than in Athletes.

Authors:  Renata Rodrigues Teixeira de Castro; Sabrina Pedrosa Lima; Allan Robson Kluser Sales; Antonio Claudio Lucas da Nóbrega
Journal:  Arq Bras Cardiol       Date:  2017-09       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.